VISFO
Consulting
Launch sequence optimization
Determine tactical market launch strategies for new a pharmaceutical product based on market opportunity.
"With VISFO’s precision intelligence and collaborative approach, our team ensures you have the right insights, at the right time, to make the best possible strategic decisions."
Dr. Louise Street-Docherty
VP Strategic Intelligence
“With deep research roots and peer-reviewed expertise in digital insight, we help teams cut through noise to uncover what truly shapes outcomes, ensuring every decision is informed by what matters most.”
Dr. Simon Leigh
Director of Research & Insights
Strategic framework
Leverage our experience and expertise to establish your asset evaluation strategy, forecast clinical and launch success, and remain agile in an evolving market.
Clinical landscaping
- Inform launch sequence prioritization through analysis of burden of disease and unmet need within target markets.
- Evaluate the size of the addressable population for your product across target markets to determine market potential.
Competitive landscaping
- Establish launch attractiveness and market opportunity though current and future competitive landscaping.
Market value and price benchmarking
- Review price corridors within target markets to inform early pricing assumptions and guide launch sequencing.
Service benefits
Prioritize launch markets
Analyze disease burden, unmet need, and addressable population to determine the most attractive launch markets.
Stay ahead of competitive market dynamics
Assess current and future competitor activity to strategically position your product and maximize market entry success.
Optimize pricing strategy for each market
Leverage price corridor analysis and market value benchmarks to guide sequencing and ensure sustainable reimbursement potential.
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
